Innovative neurosurgical technologies for epilepsy.
NxNeuro is developing technologies to treat patients suffering from refractory epilepsy. These are epilepsies that cannot be treated by drugs, leaving 4,800,000 patients in a therapeutic impasse.
Thanks to our patented technologies, we help healthcare professionals to better manage these patients suffering from severe epilepsies. 🏥
NxNeuro medical devices enable more effective diagnosis and treatment, offering the chance of a cure to as many people as possible.
Our goals: to treat more, to treat better, to treat without waiting, to give disease no chance. 🧠⚕️
If you too would like to join us in the fight against epilepsy, don't wait any longer, contact us! 💬
The future of neurotechs is Next ! 🚀
Next Neurotech unveils the future of diagnosis and surgical treatment of drug-resistant epilepsy.
Corporate | Type | Tweets | Articles | |
---|---|---|---|---|
La Région Occitanie / Pyrénées-Méditerranée National and local authorities, Government Administration | La Région Occitanie / Pyrénées-Méditerranée National and local authorities, Government Administration | Other 13 Dec 2024 | | |
CCI Gard Chamber of commerce, Government Administration | CCI Gard Chamber of commerce, Government Administration | Other 13 Dec 2024 | | |
French Tech Méditerranée French Tech, Software Development | French Tech Méditerranée French Tech, Software Development | Other 22 Oct 2024 | | |
Créalia Occitanie Civic and Social Organizations | Créalia Occitanie Civic and Social Organizations | Other 10 Jan 2024 | | |
Caisse d’Epargne Banking | Caisse d’Epargne Banking | Other 26 Feb 2024 | | |
Eurobiomed Public business cluster, Biotechnology, French Cluster, Biotechnology Research | Eurobiomed Public business cluster, Biotechnology, French Cluster, Biotechnology Research | Other 30 Jun 2024 | | |
Groupe Crédit Agricole Bank, Banking | Groupe Crédit Agricole Bank, Banking | Other 19 Mar 2024 | |